Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031212 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Daniel J Rohrbach und 6 weiteren Autor:innen. Beteiligte Einrichtung: Agilent Technologies, Winooski, Vermont, VT 05404, USA. Hauptthemen laut MEDLINE: Doxorubicin, Endoscopy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH/NCI R01.
Abstract (Originalsprache)
Liposomal doxorubicin (Dox), a treatment option for recurrent ovarian cancer, often suffers from suboptimal biodistribution and efficacy, which might be addressed with precision drug delivery systems. Here, we introduce a catheter-based endoscopic probe designed for multispectral, quantitative monitoring of light-triggered drug release. This tool utilizes red-light photosensitive porphyrin−phospholipid (PoP), which is encapsulated in liposome bilayers to enhance targeted drug delivery. By integrating diffuse reflectance and fluorescence spectroscopy, our approach not only corrects for the effects of tissue optical properties but also ensures accurate drug delivery to deep-seated tumors. Preliminary results validate the probe’s effectiveness in controlled settings, highlighting its potential for future clinical adaptation. This study sets the stage for in vivo applications, enabling the exploration of next-generation treatment paradigms for the management of cancer that involve optimizing chemotherapy administration for precision and control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Agilent Technologies, Winooski, Vermont, VT 05404, USA.
- Department of Biomedical Engineering, University at Buffalo, Buffalo, NY 14260, USA.
- Department of Biomedical, Engineering, Stony Brook University, Stony Brook, NY 11794, USA.
ORCID-Profile: Jonathan F Lovell, Ulas Sunar
Förderung
- NCI NIH HHS
- NIH/NCI R01
Zitieren
APA
Rohrbach, D. J., Carter, K. A., Luo, D., Shao, S., Aygun-Sunar, S., Lovell, J. F., & Sunar, U. (2025). Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031212
Vancouver
Rohrbach DJ, Carter KA, Luo D, Shao S, Aygun-Sunar S, Lovell JF, et al. Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031212
BibTeX
@article{Rohrbach2025,
author = {Rohrbach, Daniel J and Carter, Kevin A and Luo, Dandan and Shao, Shuai and Aygun-Sunar, Semra and Lovell, Jonathan F and Sunar, Ulas},
title = {Fluence Rate-Dependent Kinetics of Light-Triggered Liposomal Doxorubicin Assessed by Quantitative Fluorescence-Based Endoscopic Probe},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031212}
}
EUVIMED